Literature DB >> 34987110

Presenilin Is Essential for ApoE Secretion, a Novel Role of Presenilin Involved in Alzheimer's Disease Pathogenesis.

Sadequl Islam1, Yang Sun1, Yuan Gao1, Tomohisa Nakamura1, Arshad Ali Noorani1, Tong Li2, Philip C Wong2, Noriyuki Kimura3, Etsuro Matsubara3, Kensaku Kasuga4, Takeshi Ikeuchi4, Taisuke Tomita5, Kun Zou6, Makoto Michikawa6.   

Abstract

Alzheimer's disease (AD) is a debilitating dementia characterized by progressive memory loss and aggregation of amyloid-β (Aβ) protein into amyloid plaques in patient brains. Mutations in presenilin (PS) lead to abnormal generation of Aβ, which is the major cause of familial AD (FAD), and apolipoprotein E4 (ApoE4) is the major genetic risk factor for sporadic AD (SAD) onset. However, whether dysfunction of PS is involved in the pathogenesis of SAD is largely unknown. We found that ApoE secretion was completely abolished in PS-deficient cells and markedly decreased by inhibition of γ-secretase activity. Blockade of γ-secretase activity by a γ-secretase inhibitor, DAPT, decreased ApoE secretion, suggesting an important role of γ-secretase activity in ApoE secretion. Reduced ApoE secretion is also observed in nicastrin-deficient cells with reduced γ-secretase activity. PS deficiency enhanced nuclear translocation of ApoE and binding of ApoE to importin α4, a nuclear transport receptor. Moreover, the expression of PS mutants in PS-deficient cells suppressed the restoration effects on ApoE secretion compared with the expression of wild-type PS. Plasma ApoE levels were lower in FAD patients carrying PS1 mutations compared with normal control subjects. Our findings suggest a novel role of PS contributing to the pathogenesis of SAD by regulating ApoE secretion.SIGNIFICANCE STATEMENT Familial AD (FAD) typically results from mutations in the genes encoding amyloid precursor protein, presenilin 1 (PS1), or PS2. Many PS mutants have been found to exert impaired γ-secretase activity and increased amyloid-β 42 (Aβ42)/Aβ40 ratio, which induce early amyloid deposition and FAD. On the other hand, apolipoprotein E4 (ApoE4) is the major genetic risk factor for sporadic AD (SAD) and contributes to AD pathogenesis because it has reduced Aβ clearance capability compared with ApoE3 and ApoE2. FAD and SAD have long been considered to be caused by these two independent mechanisms; however, for the first time, we demonstrated that PS is essential for ApoE secretion and PS mutants affected ApoE secretion in vitro and in human samples, suggesting a novel mechanism by which PS is also involved in SAD pathogenesis.
Copyright © 2022 the authors.

Entities:  

Keywords:  apolipoprotein E; familial AD; presenilin; secretion; sporadic AD

Mesh:

Substances:

Year:  2022        PMID: 34987110      PMCID: PMC8883866          DOI: 10.1523/JNEUROSCI.2039-21.2021

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.709


  57 in total

1.  A novel presenilin 1 mutation (L282F) in familial Alzheimer's disease.

Authors:  Tsuyoshi Hamaguchi; Akiyoshi Morinaga; Tamao Tsukie; Ryozo Kuwano; Masahito Yamada
Journal:  J Neurol       Date:  2009-05-09       Impact factor: 4.849

2.  Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.

Authors:  Joseph M Castellano; Jungsu Kim; Floy R Stewart; Hong Jiang; Ronald B DeMattos; Bruce W Patterson; Anne M Fagan; John C Morris; Kwasi G Mawuenyega; Carlos Cruchaga; Alison M Goate; Kelly R Bales; Steven M Paul; Randall J Bateman; David M Holtzman
Journal:  Sci Transl Med       Date:  2011-06-29       Impact factor: 17.956

Review 3.  Alzheimer mechanisms and therapeutic strategies.

Authors:  Yadong Huang; Lennart Mucke
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

4.  Familial Alzheimer's disease co-segregates with a Met146I1e substitution in presenilin-1.

Authors:  P Jørgensen; C Bus; N Pallisgaard; M Bryder; A L Jørgensen
Journal:  Clin Genet       Date:  1996-11       Impact factor: 4.438

5.  Gamma-secretase composed of PS1/Pen2/Aph1a can cleave notch and amyloid precursor protein in the absence of nicastrin.

Authors:  Guojun Zhao; Zhenyi Liu; Ma Xenia G Ilagan; Raphael Kopan
Journal:  J Neurosci       Date:  2010-02-03       Impact factor: 6.167

6.  Suppressor Mutations for Presenilin 1 Familial Alzheimer Disease Mutants Modulate γ-Secretase Activities.

Authors:  Eugene Futai; Satoko Osawa; Tetsuo Cai; Tomoya Fujisawa; Shoichi Ishiura; Taisuke Tomita
Journal:  J Biol Chem       Date:  2015-11-11       Impact factor: 5.157

7.  Inhibition of γ-Secretase Leads to an Increase in Presenilin-1.

Authors:  Aitana Sogorb-Esteve; María-Salud García-Ayllón; Marta Llansola; Vicente Felipo; Kaj Blennow; Javier Sáez-Valero
Journal:  Mol Neurobiol       Date:  2017-08-16       Impact factor: 5.590

8.  Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs.

Authors:  Paul A Parcon; Meenakshisundaram Balasubramaniam; Srinivas Ayyadevara; Richard A Jones; Ling Liu; Robert J Shmookler Reis; Steven W Barger; Robert E Mrak; W Sue T Griffin
Journal:  Alzheimers Dement       Date:  2017-09-22       Impact factor: 21.566

9.  Biological function of Presenilin and its role in AD pathogenesis.

Authors:  Shuting Zhang; Mingming Zhang; Fang Cai; Weihong Song
Journal:  Transl Neurodegener       Date:  2013-07-17       Impact factor: 8.014

10.  An atomic structure of human γ-secretase.

Authors:  Xiao-Chen Bai; Chuangye Yan; Guanghui Yang; Peilong Lu; Dan Ma; Linfeng Sun; Rui Zhou; Sjors H W Scheres; Yigong Shi
Journal:  Nature       Date:  2015-08-17       Impact factor: 49.962

View more
  2 in total

1.  Presenilin Deficiency Increases Susceptibility to Oxidative Damage in Fibroblasts.

Authors:  Kun Zou; Sadequl Islam; Yang Sun; Yuan Gao; Tomohisa Nakamura; Hiroto Komano; Taisuke Tomita; Makoto Michikawa
Journal:  Front Aging Neurosci       Date:  2022-06-16       Impact factor: 5.702

Review 2.  Iron Deposition in Brain: Does Aging Matter?

Authors:  Eleonora Ficiarà; Ilaria Stura; Caterina Guiot
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.